This has prompted drug makers to release dedicated weight-loss versions of these diabetes drugs as well
Discontinue use and consult a professional if you develop persistent irritation
FDA status explained The regulatory distinction between Ozempic and compounded semaglutide is real and worth understanding clearly, without overstating what it means in practice
For those who do not achieve glycemic targets with lifestyle therapy, metformin, and SGLT2i, or who cannot tolerate these agents, whether due to adverse events or because other restrictions apply, other medications are recommended
FDA Approves Higher-exposure level parenteral-route administration Semaglutide [PMID: 41931277] Laboratory literature summary: FDA Approves Higher-exposure level parenteral-route administration Semaglutide
The most commonly reported side effects include: Nausea and vomiting Diarrhoea or constipation Stomach pain and bloating Dizziness Headache or fatigue Low blood sugar (more likely in people with type 2 diabetes, especially when Wegovy is taken with other diabetes medication) Acid reflux and heartburn Insulin resistance Symptoms tend to vary from person to person, and most should settle as your body gets used to the medication